Compare Workday Inc (WDAY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Workday IncTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Workday Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Workday Inc trades at $140.65 (market cap $36.36B), while State Street SPDR S&P Biotech ETF trades at $154.42. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.

	WDAY	XBI
Market Cap	$36.36B	—
Sector	Technology	Broad Market / Factor
52-Week High	$247.69	$164.28
52-Week Low	$112.55	$85.16
Enterprise Value	$35.81B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

WDAY

Workday Rising 2026 to showcase AI-driven HR, finance tools with 400+ sessions and Kelly Clarkson performancePRNewsWire · 12 hours agoBullish View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About Workday Inc

Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.